New Pivotal Data Demonstrate Superiority of Apellis’ Pegcetacoplan to Eculizumab in Improving Hemoglobin Levels, Independent of Prior Transfusions, in PNH

    NEXT STORY
    CRISPR Therapeutics and Vertex Announce New Clinical Data for Investigational Gene-Editing Therapy CTX001™ in Severe Hemoglobinopathies at the 25th Annual European Hematology Association (EHA) Congress
    PREV STORY
    Vaxcyte Announces Pricing of Upsized Initial Public Offering
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Elsalys Biotech expands its team to strengthen its strategy and the development of its programs

    ELSALYS BIOTECH EXPANDS ITS TEAM TO STRENGTHEN ITS STRATEGY AND THE DEVELOPMENT OF ITS ...

    author_avatar
    NASDAQ Market News

    INC Research Expands Presence in Japan with New Osaka Office

    RALEIGH, N.C., May 25, 2016 (GLOBE NEWSWIRE) -- INC Research Holdings, Inc. (Nasdaq:INCR), a ...

    author_avatar
    NASDAQ Market News

    Inventiva annonce la publication d’un article scientifique sur le rôle des PPAR dans le traitement de la NASH dans la revue médicale « Nature Review Gastroenterology & Hepatology »

    author_avatar
    NASDAQ Market News